Hyperglycemia-induced embryonic dysmorphogenesis correlates with genomic DNA mutation frequency in vitro and in vivo

Diabetes

Volumn 48, Issue 2, 1999, Pages 371-376

  Lee, Annette T ^a   Reis, Diane ^a   Eriksson, Ulf J ^b  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EMBRYOPATHY; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GROWTH RETARDATION; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RAT; SEQUENCE ANALYSIS; TERATOGENESIS;

ABNORMALITIES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BACTERIAL PROTEINS; DNA; ESCHERICHIA COLI PROTEINS; FEMALE; GENE FREQUENCY; GENOME; HYPERGLYCEMIA; MICE; MICE, INBRED STRAINS; MUTATION; ORGAN CULTURE TECHNIQUES; PREGNANCY; PREGNANCY COMPLICATIONS; RATS; RATS, SPRAGUE-DAWLEY; REPRESSOR PROTEINS;

EID: 0032970019     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.2.371     Document Type: Article

References (52)

1. Mølsted-Pedersen L, Tygstrups I, Pedersen J: Congenital malformations in newborn infants of diabetic women: correlation with maternal diabetic vascular complications. Lancet i:1124-1120, 1964
2. Kucera J: Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 7:61-70, 1971
3. Leslie RDG, Pyke DA, John PN, White JM: Hemoglobin A1 in diabetic pregnancy. Lancet ii:958-959, 1978
4. Jovanovic L, Druzin M, Petersen CM: Effects of euglycemia on the outcome of pregnancy in insulin-dependent diabetic women as compared with normal control subjects. Am J Med 68:105-112, 1980
5. Miller E, Hare JW, Cloherty JP, Dunn PJ, Gleason RE, Soeldner JS, Kitzmiller JL: Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 304:1331-1334, 1981
6. Mills JL: Malformations in infants of diabetic mothers. Teratology 25:385-394, 1982
7. Becerra JE, Khoury MJ, Cordero JF, Erickson JD: Diabetes mellitus during pregnancy and the risks for special birth defects: a population-based case-control study. Pediatrics 85:1-9, 1990
8. Martinez-Frias ML: Epidemiological analysis of outcomes of pregnancy in diabetic mothers: identification of the most characteristic and most frequent congenital anomalies Am J Med Gen 51:108-113, 1994
9. Cockroft DL, Coppola PT: Teratogenic effects of excess glucose on head-fold rat embryos in culture. Teratology 16:141-146, 1977
10. Horton WE, Sadler TW: Effects of maternal diabetes on early embryogenesis: alterations in morphogenesis produced by the ketone body β-hydroxybutyrate. Diabetes 32:610-616, 1983
11. Eriksson UJ, Borg LAH: Diabetes and embryonic malformations: role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 42:411-419, 1993
12. Sadler TW, Phillips LS, Balkan W, Goldstein S: Somatomedin inhibitors from diabetic rat serum alter growth and development of mouse embryos in culture. Diabetes 35:861-865, 1986
13. Deuchar EM: Embryonic malformations in rat resulting from maternal diabetes: preliminary observation. J Embryol Exp Morphol 41:93-99, 1977
14. Sadler TW: Effects of maternal diabetes on early embryogenesis. I. The teratogenic potential of diabetic serum. Teratology 21:339-347, 1980
15. Rashbass P, Ellington SKL: Development of rat embryo cultures in serum prepared from rats with streptozotocin-induced diabetes. Teratology 37:51-61, 1988
16. Buchanan TA, Denno KM, Sipos GF, Sadler TW: Diabetic teratogenesis: in vitro evidence for a multifactorial etiology with little contribution from glucose per se. Diabetes 43:656-660, 1994
17. Wentzel P, Eriksson UJ: Insulin treatment fails to abolish the teratogenic potential of serum from diabetic rats. Eur J Endocrinol 134:459-476, 1996
18. Wentzel P, Thunberg L, Eriksson IJ: Teratogenic effect of diabetic serum if prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture. Diabetologia 40:7-14, 1997
19. Sadler TW: Effects of maternal diabetes on early embryogenesis. II. Hyperglycemia-induced exencephaly. Teratology 21:349-356, 1980
20. Garnham EA, Beck F, Clark CA, Stanisstreet M: Effects of glucose on rat embryos in culture. Diabetologia 25:291-295, 1993
21. Eriksson UJ, Borg LAH: Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34:325-331, 1991
22. Hagay ZY, Weiss Y, Zusman I, Peled-Kamar M, Eriksson UJ, Groner Y: Prevention of hyperglycemia-associated embryopathy by embryonic overexpression of the free radical scavenger copper zinc superoxide dismutase gene. Am J Obstet Gynecol 173:1036-1041, 1995
23. Suzuki N, Svensson K, Eriksson UJ: High glucose concentrations inhibit migration of rat cranial neural crest cells in vitro. Diabetologia 39:401-411, 1996
24. Yang X, Borg LAH, Eriksson UJ: Altered metabolism and superoxide generation in neural tissue of rat embryos exposed to high glucose. Am J Physiol 272 (Endocrinol Metab 35) E173-E180, 1997
25. Eriksson UJ, Simán CM: Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in the offspring. Diabetes 45:1497-1502, 1996
26. Viana M, Herrera E, Bonet B: Teratogenic effects of diabetes mellitus in the rat: prevention with vitamin E. Diabetologia 39:1041-1046, 1996
27. Sivan E, Reece EA, Wu YK, Homko CJ, Polansky M, Borenstein M: Dietary vitamin F. prophylaxis and diabetic embryopathy: morphologic and biochemical analysis. Am J Obstet Gynecol 175:793-799, 1996
28. Siman CM, Eriksson UJ: Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes 46:1054-1061, 1997
29. Siman CM, Eriksson UJ: Malformations in the offspring of diabetic rats are prevented by supplementation of the maternal diet with vitamin C. Diabetologia 40:1416-1424, 1997
30. Kohler SW, Provost GS, Fieck A, Kretz PL, Bullock WO, Sorge JA, Putman DL, Short JM: Spectra of spontaneous and mutagen-induced mutations in the lacI transgenic mice. Proc Natl Acad Sci U S A 88:7958-7962, 1991
31. Provost GS, Mirsalis JC, Rogers BJ, Short JM: Mutagenic response to benzene and Tris(2,3-dibromopropyl)-phosphate in the lambda lacI transgenic mouse mutation assay. Environ Mol Mutagen 28:342-347, 1990
32. Davies R, Oreffo VI, Bayliss S, Dinh PA, Lilley KS, White INH, Smith LL, Styles JA: Mutational spectra of tamoxifen-induced mutations in the livers of lacI transgenic rats. Environ Mol Mutagen 28:430-433, 1996
33. Tao KS, Urlando C, Heddle JA: Comparison of somatic mutation in a transgenic versus host locus. Proc Natl Acad Sci U S A 90:10681-10685, 1933
34. New DAT: Whole embryo culture and the study of mammalian embryos during organogenesis. Biol Rev 53:81-122, 1978
35. Eriksson UJ: Importance of genetic predisposition and maternal environment for the occurrence of congenital malformations in offspring of diabetic rats. Teratology 37:365-375, 1988
36. Eriksson UJ, Borg LAH, Forsberg H, Siman CM, Suzuki N, Yang X: Can fetal loss be prevented? The biochemical basis of diabetic embryopathy. Diabetes Rev 4:49-69, 1996
37. Lee AT, Plump A, DeSimone C, Cerami A, Bucala R: A role for DNA mutations in diabetes associated teratogenesis in transgenic embryos. Diabetes 44:20-24, 1995
38. Beckman DA, Brent RL: Mechanisms of teratogenesis. Ann Rev Pharmacol Toxicol 24:483-500, 1984
39. Brown NA: Teratogenicity testing in vitro: status of validation studies. Arch Toxicol Suppl 11:105-114, 1987
40. Trocino RA, Akazawa S, Ishibashi M, Matsumoto K, Matsuo H, Yamamoto H, Goto S, Urata Y, Knodo T, Nagataki S: Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture. Diabetes 44:992-998, 1995
41. Brownlee M: Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46:223-234, 1995
42. Lee AT, Cerami A: Glycation. In Encyclopedia of Gerontology. Vol 1. Birremn JE, Ed. New York, Academic Press, p. 605-609, 1996
43. Pollak A, Selzeer HE, Lischka A, Hayde M: Nonenzymatic glycation of fetal tissue in diabetic pregnancy. Acta Paediatr Scand 77:481-488, 1988
44. Eriksson UJ, Wentzel P, Minhas HS, Thornally PJ: High 3-deoxyglucosone (3-DG) concentration in malformed rat embryos in vitro (Abstract). Diabetologia 40 (Suppl. 1):A233, 1997
45. Niwa T, Takeda N, Yoshizumi H, Tatematsu A, Ohara M, Tomiyama S, Niimura K: Presence of 3-deoxyglucosone, a potent protein crosslinking intermediate of Maillard reaction, in diabetic serum. Biochem Biophys Res Commun 196:837-843, 1993
46. Niwa T, Takashi M, Tomoyuki K, Tatemichi N, Takei Y: Serum levels of 3-deoxyglucosone and tissue contents of advanced glycation end products are increased in streptozotocin-induced diabetic rats with nephropathy. Nephron 74:580-585, 1996
47. Goldman AS, Baker L, Piddington R, Marx B, Herold R, Egler J: Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid. Proc Natt Acad Sci U S A 82:8227-8231, 1985
48. Baker L, Piddington R, Goldman A, Egler J, Moehring J: myo-inositol and prostaglandins reverse the glucose inhibition of neural tube fusion in cultured mouse embryos. Diabetologia 33:593-596, 1990
49. 2 prevents anomalies induced by hyperglycemia or diabetes serum in mouse embryos. Diabetes 41:1644-1650, 1992
50. Wentzel P, Eriksson UJ: Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro. Diabetes 47:677-684, 1998
51. Hod M, Star S, Passonneau JV, Unterman TG, Freinkel N: Effect of hyperglycemia on sorbitol and myo-inositol content of cultured rat conceptus: failure of aldose reductase inhibitors to modify myo-inositol depletion and dysmorphogenesis. Biochem Biophys Res Commun 140:974-980, 1986
52. Lyons TJ: Glycation, oxidation, and glycoxidation reactions in the development of diabetic complications. In Dialysis-Related Amyloidosis. Vol. 112. Shinzato MK, Ed. Karger, Basel, 1995, p. 1-10